D2-40 Immunoreactivity of Lymphatic Vessels Endothelium and Representation of Lymphatic Vessels in the Liver of Human Fetuses of Different Gestational Age
SummaryIn the reference literature, there are a few studies on the development of the lymphatic system in the liver, especially human. This study aims to establish the presence, time of appearance, distribution and representation of expression D2-40 molecule – a marker of lymph vessels endothelial cells during the fetal period of the human liver development.The livers obtained from 20 human fetuses (10 male and 12 female), aged 12-37 gestational weeks, constituted our study material. Paraffin sections, 4 µm thick, were stained with hematoxylin and eosin for histological analysis, and with LSAB2/HRP method for immunohistochemistry using the D2-40 monoclonal antibody to mark lymphatic endothelial cells. The presence of lymphatic vessels was determined by morphometry, calculating their numerical and volume density.The study showed that expression of D2-40 molecule was absent in the liver lymphatic vessels in the first trimester of development, while in the second trimester intensive D2-40 immunoreactivity was observed in the lymph vessels of the liver capsule, and low D2-40 immunopositivity of the lymph vessels in large portal spaces. In the third trimester, intensive D2-40 immunoreactivity was observed in the lymph vessels of the liver capsule and in the endothelium of numerous lymphatic vessels of various shape and size, located in the smaller and larger portal areas. Volume and numerical density of lymphatic vessels in the portal areas of the liver during fetal development increased from the second to the third trimester of pregnancy, which was proportional to the increase in volume density of the hepatic portal spaces. Based on the obtained results, a conclusion may be drawn that the lymph vessels in the liver can be identified in the first half of the second trimester, and their number was growing proportionally by the end of pregnancy.
References
1.
Si-Tayeb K, Lemaigre FP, Duncan SA. Organogenesis and Development of the Liver. Developmental Cell. 2010;18(2):175–89.
2.
Fujii T, Zen Y, Sato Y, Sasaki M, Enomae M, Minato H, et al. Podoplanin is a useful diagnostic marker for epithelioid hemangioendothelioma of the liver. Modern Pathology. 2008;21(2):125–30.
3.
Abe S ichi, Suzuki M, Cho KH, Murakami G, Cho BH, Ide Y. Cd34-positive developing vessels and other structures in human fetuses: an immunohistochemical study. Surgical and Radiologic Anatomy. 2011;33(10):919–27.
4.
Ohtani O, Ohtani Y. Lymph Circulation in the Liver. The Anatomical Record. 2008;291(6):643–52.
5.
Arimoto J, Ikura Y, Suekane T, Nakagawa M, Kitabayashi C, Iwasa Y, et al. Expression of LYVE-1 in sinusoidal endothelium is reduced in chronically inflamed human livers. Journal of Gastroenterology. 2010;45(3):317–25.
6.
Gordon EJ, Gale NW, Harvey NL. Expression of the hyaluronan receptor LYVE‐1 is not restricted to the lymphatic vasculature; LYVE‐1 is also expressed on embryonic blood vessels. Developmental Dynamics. 2008;237(7):1901–9.
7.
Prevo R, Banerji S, Ferguson DJP, Clasper S, Jackson DG. Mouse LYVE-1 Is an Endocytic Receptor for Hyaluronan in Lymphatic Endothelium. Journal of Biological Chemistry. 2001;276(22):19420–30.
8.
Jurisic G, Detmar M. Lymphatic endothelium in health and disease. Cell and Tissue Research. 2009;335(1):97–108.
9.
Collardeau‐Frachon S, Scoazec J. Vascular Development and Differentiation During Human Liver Organogenesis. The Anatomical Record. 2008;291(6):614–27.
10.
Wigle JT, Oliver G. Prox1 Function Is Required for the Development of the Murine Lymphatic System. Cell. 1999;98(6):769–78.
11.
Gale NW, Prevo R, Espinosa J, Ferguson DJ, Dominguez MG, Yancopoulos GD, et al. Normal Lymphatic Development and Function in Mice Deficient for the Lymphatic Hyaluronan Receptor LYVE-1. Molecular and Cellular Biology. 2007;27(2):595–604.
12.
Pusztaszeri MP, Seelentag W, Bosman FT. Immunohistochemical Expression of Endothelial Markers CD31, CD34, von Willebrand Factor, and Fli-1 in Normal Human Tissues. Journal of Histochemistry & Cytochemistry. 2006;54(4):385–95.
13.
Semo J, Nicenboim J, Yaniv K. Development of the lymphatic system: new questions and paradigms. Development. 2016;143(6):924–35.
14.
XU H. Expression of a lymphatic endothelial cell marker in benign and malignant vascular tumors*1. Human Pathology. 2004;35(7):857–61.
15.
Banerji S, Ni J, Wang SX, Clasper S, Su J, Tammi R, et al. LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for Hyaluronan. The Journal of Cell Biology. 1999;144(4):789–801.
16.
Petrova TV. Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. The EMBO Journal. 2002;21(17):4593–9.
17.
Yamauchi Y, Michitaka K, Onji M. Morphometric Analysis of Lymphatic and Blood Vessels in Human Chronic Viral Liver Diseases. The American Journal of Pathology. 1998;153(4):1131–7.
18.
Jackson D. The Lymphatics Revisited New Perspectives from the Hyaluronan Receptor LYVE-1. Trends in Cardiovascular Medicine. 2003;13(1):1–7.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
